Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aberrant puberty.

M B Foster1

  • 1Department of Pediatrics, University of Louisville School of Medicine, Kentucky.

Obstetrics and Gynecology Clinics of North America
|March 1, 1992
PubMed
Summary
This summary is machine-generated.

Understanding cellular processes allows clinicians to diagnose and treat pubertal disorders. Delayed and precocious puberty are classified based on gonadotropin levels and central axis activation, guiding effective patient management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correlation between glycemic control and menstruation in diabetic adolescents.

The Journal of reproductive medicine·2000
Same author

Disorders of puberty.

American family physician·1999
Same author

HLA type and the genetic risk for type 1 diabetes mellitus.

The Journal of the Kentucky Medical Association·1991
Same author

Treating children with type I diabetes mellitus: choosing an appropriate nutritional treatment strategy.

The Diabetes educator·1988
Same author

Diabetes in adolescence.

The Journal of the Kentucky Medical Association·1986
Same author

Problems in the control in insulin-dependent diabetes mellitus in children.

The Journal of the Kentucky Medical Association·1983
Same journal

Bridging Science and Practice in Gender-Affirming Care: A Compendium for Gynecologists.

Obstetrics and gynecology clinics of North America·2026
Same journal

Evidence, Clinical Expertise, and Research Gaps in Gender-Affirming Care.

Obstetrics and gynecology clinics of North America·2026
Same journal

Evaluation and Management of the Pediatric Gender-Diverse Patient.

Obstetrics and gynecology clinics of North America·2026
Same journal

Expanding Access to Cervical Cancer Screening for Transgender and Nonbinary Individuals.

Obstetrics and gynecology clinics of North America·2026
Same journal

Updates on Breast Cancer Screening and Special Considerations for Transgender Men and Women.

Obstetrics and gynecology clinics of North America·2026
Same journal

Contraceptive Needs of the Transmasculine Patient.

Obstetrics and gynecology clinics of North America·2026
See all related articles

Area of Science:

  • Endocrinology
  • Cellular Biology
  • Developmental Biology

Background:

  • Pubertal aberrations can be explained by cellular-level processes controlling tissue function and animal development.
  • Understanding these processes offers practical clinical value for diagnosing and managing pubertal disorders.

Purpose of the Study:

  • To categorize pubertal aberrations based on cellular and hormonal mechanisms.
  • To guide clinical workup and therapeutic approaches for delayed and precocious puberty.

Main Methods:

  • Classification of delayed puberty into hypergonadotropic and hypogonadotropic hypogonadism based on gonadotropin levels.
  • Categorization of precocious puberty based on central control axis activation.
  • Utilizing advances in imaging technology and peptide-based therapies.

Related Experiment Videos

Main Results:

  • Delayed puberty patients are grouped by primary gonadal failure or central control axis issues.
  • Precocious puberty patients are distinguished by normal or abnormal central axis activation.
  • Diagnostic and therapeutic strategies are determined by patient classification.

Conclusions:

  • Cellular biology concepts provide a framework for understanding pubertal aberrations.
  • Accurate classification of pubertal disorders is crucial for appropriate clinical management.
  • Advances in diagnostics and therapeutics have revolutionized the treatment of conditions like centralis precocious puberty (CPP).